课题基金 / 基金详情

Decentralized differentially-private methods for dynamic data release and analysis

Decentralized differentially-private methods for dynamic data release and analysis
用于动态数据发布和分析的去中心化差分隐私方法
批准号:
9239100
负责人:
Xiaoqian Jiang
金额:
$61.12万
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-01-01 至 2020-12-31

项目摘要

项目成果

Xiaoqian Jiang的其他基金

相似基金

相关文献

中文摘要
翻译
项目总结 数据共享和信息交换在生物医学数据中发挥着至关重要的作用 科学提高护理质量,加速发现,促进有意义的 二次利用临床资料。但隐私是公众的一大担忧。现有 分布式数据分析方法不能解决安全和隐私问题 交换中间统计数据,并且它们无法处理动态数据库更新 很好。该项目旨在设计和实施差异化-私有 用于动态数据传播和分析的分散方法。我们计划使用 来自公共领域和地方机构的基因组和临床数据(UCSD和 埃默里)仔细评估我们提出的新方法的可行性和效率。
英文摘要
PROJECT SUMMARY Data sharing and information exchange are playing critical roles in biomedical data science to improve quality of care, accelerate discovery, and promote meaningful secondary use of clinical data. But privacy is a big concern to the public. Existing distributed data analysis methods do not address the security and privacy issues in exchanging intermediary statistics and they cannot handle dynamic database updates very well. This project aims at designing and implementing differentially-private decentralized methods for dynamic data dissemination and analysis. We plan to use genomic and clinical data from both public domain and local institutions (UCSD and Emory) to carefully evaluate the feasibility and efficiency of our proposed new methods.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Robust privacy preserving distributed analysis platform for cancer research: addressing data bias and disparities
  • 批准号:
    10642562
  • 项目类别:
  • 资助金额:
    $41.19万
  • 财政年份:
    2023
  • 负责人:
    Xiaoqian Jiang
  • 依托单位:
Harmonizing multiple clinical trials for Alzheimer's disease to investigate differential responses to treatment via federated counterfactual learning
iDASH Genome Privacy and Security Competition Workshop
Decentralized differentially-private methods for dynamic data release and analysis
  • 批准号:
    10740597
  • 项目类别:
  • 资助金额:
    $61.37万
  • 财政年份:
    2023
  • 负责人:
    Xiaoqian Jiang
  • 依托单位:
国内基金
海外基金
Molecular Interaction Reconstruction of Rheumatoid Arthritis Therapies Using Clinical Data